Nurix Therapeutics Inc (NRIX)
13.75
-0.38
(-2.69%)
USD |
NASDAQ |
Apr 24, 16:00
13.74
0.00 (0.00%)
After-Hours: 20:00
Nurix Therapeutics Market Cap: 839.68M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 839.68M |
| April 23, 2024 | 862.88M |
| April 22, 2024 | 829.30M |
| April 19, 2024 | 829.91M |
| April 18, 2024 | 881.81M |
| April 17, 2024 | 859.83M |
| April 16, 2024 | 894.64M |
| April 15, 2024 | 759.87M |
| April 12, 2024 | 822.78M |
| April 11, 2024 | 845.89M |
| April 10, 2024 | 771.18M |
| April 09, 2024 | 859.16M |
| April 08, 2024 | 678.28M |
| April 05, 2024 | 683.20M |
| April 04, 2024 | 685.16M |
| April 03, 2024 | 717.11M |
| April 02, 2024 | 730.38M |
| April 01, 2024 | 716.62M |
| March 28, 2024 | 722.52M |
| March 27, 2024 | 714.65M |
| March 26, 2024 | 639.94M |
| March 25, 2024 | 665.01M |
| March 22, 2024 | 659.60M |
| March 21, 2024 | 639.94M |
| March 20, 2024 | 652.54M |
| Date | Value |
|---|---|
| March 19, 2024 | 626.01M |
| March 18, 2024 | 630.92M |
| March 15, 2024 | 642.71M |
| March 14, 2024 | 689.88M |
| March 13, 2024 | 711.50M |
| March 12, 2024 | 706.59M |
| March 11, 2024 | 694.31M |
| March 08, 2024 | 729.68M |
| March 07, 2024 | 712.49M |
| March 06, 2024 | 769.49M |
| March 05, 2024 | 655.49M |
| March 04, 2024 | 661.38M |
| March 01, 2024 | 666.30M |
| February 29, 2024 | 606.84M |
| February 28, 2024 | 582.33M |
| February 27, 2024 | 580.86M |
| February 26, 2024 | 545.17M |
| February 23, 2024 | 498.72M |
| February 22, 2024 | 515.83M |
| February 21, 2024 | 490.90M |
| February 20, 2024 | 493.34M |
| February 16, 2024 | 482.58M |
| February 15, 2024 | 481.61M |
| February 14, 2024 | 450.31M |
| February 13, 2024 | 426.36M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
206.14M
Minimum
Oct 25 2023
2.037B
Maximum
Mar 17 2021
846.17M
Average
695.44M
Median
Market Cap Benchmarks
| Gilead Sciences Inc | 83.57B |
| ALX Oncology Holdings Inc | 813.47M |
| Vanda Pharmaceuticals Inc | 262.37M |
| GlycoMimetics Inc | 119.56M |
| Immunic Inc | 111.70M |
Market Cap Related Metrics
| PS Ratio | 9.271 |
| Price to Book Value | 4.974 |
| Price | 13.75 |
| Earnings Yield | -19.35% |